CureSilk Patch 

Medicos Biotech succeeded in mass-producing spider silk protein with excellent biocompatibility, biodegradability, and collagen regeneration for the first time in the world, and is currently researching solutions for treating bedsores stage 3-4 and diabetic foot ulcers stage 5-6 that do not have treatments. It is also preparing to launch a treatment for intractable wounds with excellent absorbency and moist environment creation. It has a competitive edge over existing foam type, stem cell type, and growth factor type patches, and is the only substance with anti-inflammation and antibacterial properties, and is superior in efficacy, can be stored at room temperature, and is also price competitive compared to other companies.